Top CAR-T Therapy Stock by Market Performance | Edgen

Top CAR-T Therapy Stock by Market Performance | Edgen

Investment in immune cell therapy for cancer treatment, benefiting from CAR-T technology development and commercialization.

24H Performance

1.29%

Beta0.56



Stock	Price	Chg %	Price Change	YTD Chg%	Volume	Market Cap	Rating	Last 7 days

Regular Market | Last updated at Jun 25, 2026 12:56:11

Markets

News

Terms of Use Privacy Policy

© 2026 Edgen Powered by